Electrophysiologic and phenotypic features of an autosomal cone-rod dystrophy caused by a novel CRX mutation
- PMID:12359607
- DOI: 10.1016/s0161-6420(02)01187-9
Electrophysiologic and phenotypic features of an autosomal cone-rod dystrophy caused by a novel CRX mutation
Abstract
Purpose: To reexamine a large Albertan family previously reported with a progressive cone dystrophy with variable phenotype and to map the disorder using molecular genetic techniques.
Design: Observational case series.
Participants: Twenty-nine subjects (10 affected) from four generations of a large kindred were clinically examined. Twenty-three of these individuals, as well as two unaffected spouses, were included in the molecular genetic study. Subject ages ranged from 17 to 91 years of age.
Methods: Disease status and associated ocular abnormalities were assessed primarily by measurement of visual acuity, color vision, fundus photography, and both full-field and multifocal electroretinography (ERG and mfERG). Linkage of the disorder to the rhodopsin gene was studied using microsatellites. A mutational screen of the CRX gene was performed to identify coding sequence changes.
Main outcome measures: Visual acuity and color discrimination were reduced in clinically affected individuals; full-field flash ERG was used to measure function of both cones and rods. mfERG and fundus photography allowed documentation of the observed macular changes.
Results: We noted a variable, adult-onset macular dystrophy, progressing in some cases to a retinitis pigmentosa-like phenotype. Both photopic and scotopic full-field ERG amplitudes were reduced by approximately 50%, demonstrating involvement of both photoreceptor systems. A reduced b-wave amplitude with a relatively preserved a-wave was observed at both cone and rod levels. Macular involvement was confirmed by mfERG. The rhodopsin locus was excluded by haplotype analysis. A novel frameshift mutation was detected in exon III of the CRX retinal homeobox gene. ERG and molecular genetic findings were consistent with the reclassification of this disease as an autosomal dominant cone-rod dystrophy (CRD) CONCLUSIONS: We report a novel CRX mutation causing autosomal dominant CRD. Observed ERG changes suggest that this mutation primarily impairs inner retinal function. Because retinal expression of CRX is limited to photoreceptors, this dysfunction may be the result of faulty photoreceptor communication with second-order retinal neurons. We propose misexpression of gated cation channels caused by altered CRX activity as one putative mechanism by which a sole photoreceptor defect may selectively impair neurotransmission without disrupting the upstream events of phototransduction.
Similar articles
- Cone and cone-rod dystrophy segregating in the same pedigree due to the same novel CRX gene mutation.Kitiratschky VB, Nagy D, Zabel T, Zrenner E, Wissinger B, Kohl S, Jägle H.Kitiratschky VB, et al.Br J Ophthalmol. 2008 Aug;92(8):1086-91. doi: 10.1136/bjo.2007.133231.Br J Ophthalmol. 2008.PMID:18653602
- Genotype-phenotype correlation in a German family with a novel complex CRX mutation extending the open reading frame.Paunescu K, Preising MN, Janke B, Wissinger B, Lorenz B.Paunescu K, et al.Ophthalmology. 2007 Jul;114(7):1348-1357.e1. doi: 10.1016/j.ophtha.2006.10.034. Epub 2007 Feb 22.Ophthalmology. 2007.PMID:17320181Review.
- Visual phenotype in patients with Arg41Gln and ala196+1bp mutations in the CRX gene.Tzekov RT, Sohocki MM, Daiger SP, Birch DG.Tzekov RT, et al.Ophthalmic Genet. 2000 Jun;21(2):89-99.Ophthalmic Genet. 2000.PMID:10916183
- Autosomal Dominant Retinal Dystrophy With Electronegative Waveform Associated With a Novel RAX2 Mutation.Yang P, Chiang PW, Weleber RG, Pennesi ME.Yang P, et al.JAMA Ophthalmol. 2015 Jun;133(6):653-61. doi: 10.1001/jamaophthalmol.2015.0357.JAMA Ophthalmol. 2015.PMID:25789692Free PMC article.
- Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence; a review and update.Robson AG, Michaelides M, Saihan Z, Bird AC, Webster AR, Moore AT, Fitzke FW, Holder GE.Robson AG, et al.Doc Ophthalmol. 2008 Mar;116(2):79-89. doi: 10.1007/s10633-007-9087-4. Epub 2007 Nov 6.Doc Ophthalmol. 2008.PMID:17985165Free PMC article.Review.
Cited by
- Novel clinical presentation of aCRX rod-cone dystrophy.Gonzalez-Gonzalez LA, Scanga H, Traboulsi E, Nischal KK.Gonzalez-Gonzalez LA, et al.BMJ Case Rep. 2021 Apr 28;14(4):e233711. doi: 10.1136/bcr-2019-233711.BMJ Case Rep. 2021.PMID:33910785Free PMC article.
- Characteristic Ocular Features in Cases of Autosomal Recessive PROM1 Cone-Rod Dystrophy.Collison FT, Fishman GA, Nagasaki T, Zernant J, McAnany JJ, Park JC, Allikmets R.Collison FT, et al.Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2347-2356. doi: 10.1167/iovs.19-26993.Invest Ophthalmol Vis Sci. 2019.PMID:31136651Free PMC article.
- Mechanisms of blindness: animal models provide insight into distinct CRX-associated retinopathies.Tran NM, Chen S.Tran NM, et al.Dev Dyn. 2014 Oct;243(10):1153-66. doi: 10.1002/dvdy.24151. Epub 2014 Jun 27.Dev Dyn. 2014.PMID:24888636Free PMC article.Review.
- Occult Macular Dysfunction Syndrome: Identification of Multiple Pathologies in a Clinical Spectrum of Macular Dysfunction with Normal Fundus in East Asian Patients: EAOMD Report No. 5.Fujinami-Yokokawa Y, Yang L, Joo K, Tsunoda K, Liu X, Kondo M, Ahn SJ, Li H, Park KH, Tachimori H, Miyata H, Woo SJ, Sui R, Fujinami K.Fujinami-Yokokawa Y, et al.Genes (Basel). 2023 Sep 26;14(10):1869. doi: 10.3390/genes14101869.Genes (Basel). 2023.PMID:37895218Free PMC article.
- A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases.Johnson SL, Tsou WL, Prifti MV, Harris AL, Todi SV.Johnson SL, et al.Front Mol Neurosci. 2022 Sep 14;15:974167. doi: 10.3389/fnmol.2022.974167. eCollection 2022.Front Mol Neurosci. 2022.PMID:36187346Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials